Innate immune dysfunction in acute and chronic liver disease.
about
Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease.Increased occurrence of native septic arthritis in adult cirrhotic patients: a population-based three-year follow-up study in Taiwan.HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in womenTriple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes.Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study.Ascites' neutrophil function is significantly impaired in patients with decompensated cirrhosis but can be restored by autologous plasma incubation.Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions.Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation.Immune dysfunction in cirrhosis.Hemophagocytic Lymphohistiocytosis (HLH) in Children Presenting as Liver Disease.Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B.Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure.Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis.Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure.Immunodeficiency caused by cirrhosis
P2860
Q34691490-DF7B1F53-19D8-4E4D-9083-6E61116A9E8CQ34990048-09EDB893-1B59-4B8D-842B-F1B5864B6B99Q35019825-EFBFE9CE-714C-40A2-AFAA-159E1AE200C1Q35944276-A690C947-6723-41C9-A623-E2A4CDDBD5C1Q36902800-349F22C0-C404-4F8F-BDA0-FF6CBA765413Q37472117-E20ED11D-5D86-41B2-865B-AC0FA75960B2Q37903856-C01C288D-7446-46A0-80F0-F20EB4DAA18FQ37959188-62A427C2-0F76-4A8E-B408-7657FC83FE2FQ38195835-08FBA2C7-CE1A-4BEE-BE48-22437ECE339BQ40166014-9697A94F-0908-4066-84B8-8F222836D7FFQ40240357-9E67C42E-EB5A-425D-8E88-3B79953C716CQ40363376-7AE02B6E-2843-4AF8-B3C5-6F2862BFB5E7Q40518328-EF243B64-E2D8-43E6-80F9-9057DE9EE956Q42282784-EB07C8BB-B0F5-4334-BF54-FD3039E6735FQ47611244-0D65A074-F4A6-4447-9C34-5483190448F8Q48206114-9C4E5962-4D77-46EB-9CBA-CEFCE1D8523CQ57494350-4F58124A-B918-400F-88CB-3D08F1858554
P2860
Innate immune dysfunction in acute and chronic liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innate immune dysfunction in acute and chronic liver disease.
@en
Innate immune dysfunction in acute and chronic liver disease.
@nl
type
label
Innate immune dysfunction in acute and chronic liver disease.
@en
Innate immune dysfunction in acute and chronic liver disease.
@nl
prefLabel
Innate immune dysfunction in acute and chronic liver disease.
@en
Innate immune dysfunction in acute and chronic liver disease.
@nl
P2860
P1476
Innate immune dysfunction in acute and chronic liver disease.
@en
P2093
Michael Rybczynski
Ursula Mayrhauser
P2860
P2888
P304
P356
10.1007/S00508-009-1288-2
P577
2009-01-01T00:00:00Z